NEXGEL (NXGL) Competitors $3.05 +0.08 (+2.69%) Closing price 03/27/2025 03:59 PM EasternExtended Trading$3.04 -0.01 (-0.33%) As of 03/27/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. NTRB, MLSS, VANI, GUTS, ICAD, CTSO, MBOT, APT, INO, and ECORShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include Nutriband (NTRB), Milestone Scientific (MLSS), Vivani Medical (VANI), Fractyl Health (GUTS), iCAD (ICAD), Cytosorbents (CTSO), Microbot Medical (MBOT), Alpha Pro Tech (APT), Inovio Pharmaceuticals (INO), and electroCore (ECOR). These companies are all part of the "medical equipment" industry. NEXGEL vs. Nutriband Milestone Scientific Vivani Medical Fractyl Health iCAD Cytosorbents Microbot Medical Alpha Pro Tech Inovio Pharmaceuticals electroCore NEXGEL (NASDAQ:NXGL) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations. Does the media prefer NXGL or NTRB? In the previous week, NEXGEL had 8 more articles in the media than Nutriband. MarketBeat recorded 10 mentions for NEXGEL and 2 mentions for Nutriband. Nutriband's average media sentiment score of 1.44 beat NEXGEL's score of 0.86 indicating that Nutriband is being referred to more favorably in the news media. Company Overall Sentiment NEXGEL Positive Nutriband Positive Which has better valuation & earnings, NXGL or NTRB? NEXGEL has higher revenue and earnings than Nutriband. Nutriband is trading at a lower price-to-earnings ratio than NEXGEL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNEXGEL$6.73M3.08-$3.16M-$0.50-6.10Nutriband$2.02M36.09-$5.49M-$0.71-9.25 Does the MarketBeat Community prefer NXGL or NTRB? Nutriband received 3 more outperform votes than NEXGEL when rated by MarketBeat users. However, 50.00% of users gave NEXGEL an outperform vote while only 44.44% of users gave Nutriband an outperform vote. CompanyUnderperformOutperformNEXGELOutperform Votes150.00% Underperform Votes150.00% NutribandOutperform Votes444.44% Underperform Votes555.56% Is NXGL or NTRB more profitable? NEXGEL has a net margin of -52.60% compared to Nutriband's net margin of -338.51%. Nutriband's return on equity of -54.49% beat NEXGEL's return on equity.Company Net Margins Return on Equity Return on Assets NEXGEL-52.60% -71.19% -34.79% Nutriband -338.51%-54.49%-48.52% Do analysts rate NXGL or NTRB? Nutriband has a consensus target price of $13.00, indicating a potential upside of 97.87%. Given Nutriband's stronger consensus rating and higher probable upside, analysts plainly believe Nutriband is more favorable than NEXGEL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nutriband 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, NXGL or NTRB? NEXGEL has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Nutriband has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Do institutionals & insiders hold more shares of NXGL or NTRB? 2.2% of NEXGEL shares are owned by institutional investors. Comparatively, 19.7% of Nutriband shares are owned by institutional investors. 24.9% of NEXGEL shares are owned by company insiders. Comparatively, 54.1% of Nutriband shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryNutriband beats NEXGEL on 10 of the 18 factors compared between the two stocks. Remove Ads Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNEXGELSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.71M$4.42B$5.64B$8.06BDividend YieldN/A32.64%4.57%4.01%P/E Ratio-5.2628.8723.1419.03Price / Sales3.0850.00384.1193.17Price / CashN/A51.0838.1634.64Price / Book3.396.146.954.33Net Income-$3.16M$67.64M$3.20B$247.06M7 Day Performance12.96%-2.07%-2.28%-0.37%1 Month Performance-1.61%-0.48%2.88%-3.85%1 Year Performance11.72%12.88%10.87%1.27% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNEXGEL0.8938 of 5 stars$3.05+2.7%N/A+14.2%$20.71M$6.73M-5.2610Earnings ReportGap UpNTRBNutriband3.305 of 5 stars$6.57+6.0%$13.00+97.9%+62.2%$72.97M$2.02M-9.2510Short Interest ↓Positive NewsMLSSMilestone Scientific1.0152 of 5 stars$0.91-1.7%$1.25+37.4%+71.6%$70.88M$8.88M-13.0030Gap UpVANIVivani Medical3.0038 of 5 stars$1.10+0.9%$4.00+263.6%-37.8%$65.16MN/A-2.4420Analyst ForecastNews CoverageGUTSFractyl Health2.1878 of 5 stars$1.27-0.8%$10.00+687.4%-82.5%$62.13M$93,000.00-0.10102Positive NewsICADiCAD0.5092 of 5 stars$2.33+1.7%N/A+33.8%$61.84M$18.94M-17.92140Analyst UpgradePositive NewsCTSOCytosorbents2.1554 of 5 stars$1.13+2.7%$4.67+313.0%+7.5%$61.79M$33.79M-3.14220Upcoming EarningsAnalyst ForecastGap UpMBOTMicrobot Medical1.6456 of 5 stars$1.66+7.8%$9.00+442.2%+33.0%$57.68MN/A-2.0720Earnings ReportAPTAlpha Pro TechN/A$5.11-0.8%N/A-19.2%$55.56M$59.29M13.81120Analyst ForecastNews CoverageHigh Trading VolumeINOInovio Pharmaceuticals3.8727 of 5 stars$2.11+3.9%$12.40+487.7%-86.5%$55.07M$203,413.00-1.00320ECORelectroCore2.3996 of 5 stars$8.26-3.5%$25.50+208.7%+16.0%$54.98M$23.33M-4.5150Short Interest ↑High Trading Volume Remove Ads Related Companies and Tools Related Companies NTRB Alternatives MLSS Alternatives VANI Alternatives GUTS Alternatives ICAD Alternatives CTSO Alternatives MBOT Alternatives APT Alternatives INO Alternatives ECOR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NXGL Stock Free NXGL Stock Alerts